Abstract
3 Hydroxy 3 Methyl Glutaryl Coenzyme A Reductase Inhibitors’ (statins) are increasingly being used in patients with cardiovascular disease. The Scottish Intercollegiate Guidelines Network (SIGN) and National Institute of Health and Clinical Excellence (NICE) recommend their use in primary and secondary prevention of cardiovascular events. Patients on preoperative statins will frequently present for surgical procedures. The increase in adverse cardiovascular outcomes in high risk patients if statins are withheld in the immediate postoperative period should be weighed against the small but serious risk of rhabdomyolysis associated with statins. The potential for drug interactions should be considered when prescribing for patients on statins.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Indian Journal of Thoracic and Cardiovascular Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
